Open Orphan, Frenkel Topping and Chris Bailey on Taylor Wimpey, Unilever and DFS

Justin Waite
Vox Markets Podcast with Justin Waite
12:39, 23rd April 2020

Vox Media Player

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app


On today's Vox Markets Podcast: Open Orphan, Frenkel Topping and Chris Bailey on Taylor Wimpey, Unilever and DFS

Cathal Friel, Executive Chairman of Open Orphan (ORPH) FOLLOW discusses how they've commenced the testing of an anti-viral for treating COVID-19 on behalf of one of its clients.

Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. It has Europe's only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary's Hospital London. hVIVO supports product development for customers developing antivirals, vaccines and respiratory therapeutics, all particularly relevant and topical in the environment of heightened awareness of Covid-19 in 2020. The Company also has a leading portfolio of 8 viral challenge study models which are: 2 FLU, 2 RSV, 1 HRV, 1 Asthma, 1 cough and 1 COPD viral challenge models. As announced in early March, Open Orphan is rapidly advancing a Coronavirus challenge study model and expects to be very active with many companies in the development of a Covid-19 vaccine. No other company in the world has such a portfolio, with only two competitors globally having 1 challenge study model each.


Richard Fraser, CEO of Frenkel Topping (FEN) FOLLOW talks about their final results and also discusses how they think COIV19 will impact businesses.

The financial services firm consists of Frenkel Topping Limited, Ascencia Investment Management, Obiter Wealth Management and Equatas Accountants. The group of companies specialises in providing financial advice and asset protection services to clients at times of financial vulnerability, with particular expertise in the field of personal injury and clinical negligence. With more than 30 years' experience in the industry, Frenkel Topping Group has earned a reputation for commercial astuteness underpinned by a strong moral obligation to its clients, employees and wider society, with a continued focus on its Environmental, Social and Governance (ESG) impact.

 

(Interview starts at 16 minutes 19 seconds)


Chris Bailey founder of Financial Orbit covers:

Taylor Wimpey (TW.) FOLLOW

Unilever (ULVR) FOLLOW

DFS Furniture (DFS) FOLLOW

(Interview starts at 27 minutes 56 seconds)    

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Comments
Login or register to post comments

Recent Articles
Watchlist